Pancreas Transplant Outcomes

At a Glance

  • First transplant: 05/11/87
  • Transplants performed in 2020: 3
  • Total number of program transplants through 2020: 170
  • Received Medicare approval: 07/01/99

Outcomes

  • Pre-transplant mortality#: .00 (expected .025, national .05)

Adult one- and three-year patient survival rates for PAK (pancreas after kidney transplant)*:

  • Henry Ford one-year patient survival rate: 100.00%
  • Henry Ford one-year expected patient survival rate^: 95.17%
  • Henry Ford three-year patient survival rate: 66.66%
  • Henry Ford three-year expected patient survival rate^: 93.41%

Adult one- and three-year patient survival rates for PTA (pancreas transplant alone)*

  • Henry Ford one-year patient survival rate: 100.00%
  • Henry Ford one-year expected patient survival rate^: 100.00%
  • Henry Ford three-year patient survival rate^: 0%
  • Henry Ford three-year patient survival rate^: 98.28%

# Patients on the waitlist between 01/01/2020 – 03/12/2020 and 06/13/2020 – 12/31/2021

*Estimated probability of surviving at one year, for patients receiving their first transplant between 01/01/2019 -03/12/2020 and 06/13/2020 – 06/30/2021; and at three years between for patients receiving their first transplant between 07/01/2016 and 12/31/2018
^ Adjusted for patient and donor characteristics

Source: Scientific Registry of Transplant Recipients, Center and OPO-specific Reports, based on data available April 30, 2022, released July 6, 2022.

Take the next step

Speak with a Transplant Institute specialist.

X

Cookie Consent

We use cookies to improve your web experience. By using this site, you agree to our Terms of Use. Read our Internet Privacy Statement to learn what information we collect and how we use it.


Accept All Cookies